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Abstract 
Gene therapy holds great potential to enhance human medicine since it could provide 
treatment to a vast variety of diseases. Viral gene delivery vectors have high transfection 
efficiency, but often they are associated with high risk of immunogenicity as well. Non-
viral vectors, especially polycationic polymer based gene carriers provide the advantages 
of low immunogenicity and ease of synthesis, but they face two major challenges for a 
broader application in clinical trials: high toxicity and low transfection efficiency. In this 
study, we performed experiments to gain a better understanding of the mechanisms and 
pathways underlying the high toxicity and low transfection efficiency associated with 
polyplex-mediated gene delivery. In the first part of the thesis, we studied the toxicity 
resulted from polyplex-mediated gene delivery and found that polyplexes made from 
PEI/DNA plasmids were able to induce autophagy in fibroblasts, a third type of 
cytotoxicity besides apoptosis and necrosis. With the proper choice of treatment time and 
drug concentrations, we decoupled cell cytotoxicity due to apoptosis and necrosis from 
autophagy, and found that transfection efficiency is positively correlated with the 
regulation of autophagy. In the second part of the thesis, we performed in vitro physical 
characterization of polyplexes formed from six different polymers in order to understand 
their local in vivo performance. Homopolymer with a larger molecular weight (and 
polymer chain) was able to transfect cells in vitro, but not in vivo. On the other hand, a 
shorter polymer chain favored local in vivo transfection. PEGylation helped the 
polyplexes to be stable against serum protein, but PEGylation of long chain 
homopolymer did not improve its in vivo performance. Taken together, these findings 
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could help us to improve transfection efficiency through modulation of cytotoxicity 
(autophagy) and gain a better understanding of polyplex in vivo performance based on its 
in vitro behavior and therefore providing insight into the design of gene delivery vehicle. 
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Chapter 1: Introduction  
 
1.1 Non-viral vector for gene delivery 
 
Gene therapy holds tremendous potential in treating a huge variety of genetic 
disorders such as haemophilia[1], muscular dystrophy[2], cystic fibrosis[3] and 
diabetes[4], and it has been developed rapidly for treatment of cardiovascular[5], 
neurological[6], and infectious diseases[7], as well as cancer[8]. To treat diseases caused 
by a missing or aberrant protein, DNA encoding the desired gene is introduced into the 
nucleus of a cell to replace the errant gene or to alter the expression of an existing gene. 
The delivered DNA is subsequently processed into a functional protein or prodrug-
activating enzymes to kill tumor cells [9]or performing other desired functions in the 
affected cells. Historically, many deactivated viruses have been used as gene carriers and 
have been launched into clinical trials due to their high efficiency in gene transfection[10, 
11]. Viral vectors, such as adenovirus, adeno-associated virus, retrovirus and lentivirus, 
have evolved ways to overcome cellular obstacles by fusing the viral envelope with the 
endosome membrane and releasing DNA into the cytoplasm, achieving high transfection 
efficiency[12].  However, the high transfection efficiency associated with viral vectors 
comes at a cost. Despite being rendered replication deficient, viral vectors still pose 
safety concerns since they can cause immunogenicity and toxicity, and severe immune 
response in the host often leads to fatalities[13]. Limitations to cell mitosis for retrovirus, 
contamination of adenovirus and packing constraints of adeno-associated virus also 
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lesson their appeal [14]. Fundamental problems associated with viral vectors have 
encouraged extensive research into non-viral carriers, which possess the potential 
advantages of low immunogenicity, unrestricted DNA cargo size, potential for repeated 
administrations and ease of synthesis[15]. They can also address many pharmaceutical 
considerations better than viral vectors, such as scale-up, storage stability and quality 
control. However, non-viral vectors have to overcome their major limitation before they 
can be widely applied in clinical trials, which is the low transfection efficiency compared 
to the viral vectors. 
1.2 Design of cationic polymer for gene delivery 
 
Non-viral vectors consist of synthetic cationic polymers, lipids, and peptides able 
form ionic complexes with plasmid DNA. Polycationic polymers have been extensively 
investigated as gene carriers because they offer a high level of flexibility in design. A 
basic characteristic of the nucleic acid backbone is its negative charge, which allows 
electrostatic interaction with cationic polymers for form polyplexes. Due to the 
neutralization of the negative charges, DNA molecules are able to collapse into 
nanostructures in the size range of 100 nm, which are much smaller in size than free 
DNA with a size in the micrometer range [16]. The great reduction in size is one of the 
major reasons made the complexed DNA amendable to endocytic pathways. 
Physical properties such as polymer molecular weight or chain length and surface 
characteristics are important factors in the design of polycationic polymer based gene 
carriers, and they can be tuned to modulate gene delivery properties including DNA 
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binding, colloidal stability of the complex, endosomal escape, cytotoxicity and 
transfection efficiency. For different target cells and tissues, or different routes of 
administration, the optimal characteristics of the complexes would vary. In general, the 
rational design of polymer based gene carriers needs to address the key factors along the 
gene delivery pathways. 
Molecular weight or chain length of the polymer chains is a critical factor 
influencing gene delivery efficiency, and the relationship between polymer molecular 
weight and transfection efficiency has been studied in various polymers.  Hennink and 
colleagues reported that the molecular weight of poly(2-dimethylaminoethyl 
methacrylate) (PDMAEMA) significantly affected transfection efficiency, and with 
higher molecular weight favoring the high transfection efficiency[17]. Mikos and 
colleagues determined that the higher molecular weight polyethylenimine (PEI) 
transfected better than the lower molecular weight PEI [18]. On the other hand, Hashida 
and colleagues found that the lower molecular weight PEI yielded a better transfection 
result than the higher molecular weight polymer [19]. Ren and colleagues studied the 
effect of molecular weight of polyphosphoramidate (PPA) on gene transfection, and 
reported that a higher molecular weight of the polymer chain enhanced gene delivery 
efficiency [20]. Poly-L-lysine, another popular cationic polymer used as gene carrier 
besides PEI, has also been studied, and Kwoh and colleagues reported a result that the 
longer chain polymer favored transfection efficiency[21]. In general, a higher molecular 
weight favors higher gene expression, but some discrepancies exist[19]. A fundamental 
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understanding of the effect of linear polycation chain length on the gene delivery process, 
especially in the in vivo environment remains elusive. 
1.3 Cytotoxicity associated with polyplex-mediated gene transfection 
 
Besides the low transfection efficiency compared to the viral vector, another major 
hurdle stopping polymer mediated gene delivery going to clinical trials is the high 
cytotoxicity associated with polyplex-mediated gene transfer [22-24]. The understanding 
of mechanisms and pathways underling cellular cytotoxicity caused by exposure of target 
cells and tissues to polymeric non-viral delivery systems could greatly help to improve 
their safety profile drastically. Three types of cell death have been identified based on its 
morphological appearance, enzymological criteria, and functional aspects. They are 
apoptosis, necrosis and autophagy [25, 26].  
Apoptotic cell death is morphologically defined by chromatin condensation, nuclear 
fragmentation, shrinkage of the cytoplasm and formation of apoptotic bodies [27]. It is 
often accompanied by rounding-up of the cell, retraction of pseudopods, little 
ultrastructural modifications of cytoplasmic organelles, plasma membrane blebbing and 
engulfment by phagocytes in vivo [28]. This form of cell death modality is usually, but 
not exclusively, associated with caspase activation [29] mitochondrial membrane 
permeabilization [30]. Hunter and colleagues have reported that mitochondrial-mediated 
apoptosis was significant in PEI/DNA polyplex induced cytotoxicity [24]. Palumbo and 
colleagues have also confirmed the observation in their study using PEI/DNA polyplexes 
[31], and further reported that the use of the broad spectrum caspase inhibitor N-
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benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone (Z-VAD-fmk) could reduce 
apoptotic cell death. Besides PEI, poly(L-lysine) (PLL) is another intensively studied 
polymer for non-viral gene delivery. Symonds and colleagues examined the toxicity 
associated with PLL/DNA complex and reported it as apoptotic cell death [32]. They also 
discovered that apoptosis is more prominent in the high molecular weight PLL treated 
cells. 
Necrosis is morphologically characterized by an increase in cell volume, leading to 
the early rupture of the plasma membrane[26]. This process is associated with dilation 
and final dismantling of cytoplasmic materials, including mitochondria [33]. This mode 
of cell death is often the unregulated consequence of non-physiological stress or massive 
cell injury. Fisher and colleagues detected predominantly necrotic cell death in cationic 
polymer mediated gene delivery [34]. Palumbo and colleagues reported necrosis in 
PEI/DNA complex treated cells as well [31].  
Autophagy is a fundamental process of cells under stress that degrades cytoplasmic 
proteins and organelles to maintain cellular homeostasis [35]. Several pathways of 
autophagy have been identified including macroautophagy, microautophagy, chaperon-
mediated autophagy (CMA), pxenophagy and mitophagy[36, 37]. During a short period 
of nutrient deprivation, the absence of amino acids prevents signaling through 
phosphatidylinositol-3-kinase (PI3K), deactivates the autophagy regulatory molecule 
target of rapamycin (mTor), and induces macroautophagy[38]. Portions of the cytoplasm 
are sequestered into a double-membrane structure known as autophagosome, and 
degraded in lysosomes when autophagosomes fuse with lysosomes. LC3 (autophagy-
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related gene (Atg) 8) decorates the membrane of the autophagosome and it is considered 
as a distinctive autophagosome marker. Recently, it has been suggested that 
macroautophagy could be another possible mechanism involved in antigen presentation 
by MHC Class I molecules[39].  
Most studies on autophagy were focused on starvation, essential amino acid 
deprivation or stressed condition such as heat treatment [35, 38, 40]. Only one reported 
talked about autophagy induction by cationic lipid gene carrier[41]. So far, no published 
documentation has been found on whether polymeric gene carriers can induce autophagy 
and how autophagy might affect transfection. Autophagy can be activated and regulated 
by many physiological and pathological conditions including starvation[42], intracellular 
viruses and bacteria[43], calcium phosphate precipitates[44], quantum dots[45] and gold 
nanoparticles[46]. Induced autophagy has also been observed in certain cell types 
exposed to various cationic molecules alone such as polyamidoamine (PAMAM) in 
human lung A549 cells[47], PEI in nephritic and hepatic cells[48] and cationic lipids in a 
HeLa cell line[41]. Because many cationic polymers are also gene transfection reagents, 
it is important to know whether polymer/DNA complexes can induce autophagy, and 
how induced autophagy influences gene transfection. 
 
1.4 The gene delivery problem: extracellular challenges in vivo 
 
The in vivo efficiency of a polyplex delivery system depends on its ability to 
overcome both the extracellular and intracellular hurdles. The extracellular barriers for 
gene delivery involve serum proteins and components of the extracellular matrix (ECM), 
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a large proportion of which are negatively charged [49] and present potential threats to 
the stability of polyplexes. When the negatively charged biomacromolecules encounter 
the positively charged polyplexes, the polyplexes are very likely to dissociate due to the 
polyelectrolyte exchange reaction [50]. Unpacking of polyplexes due to competitive 
binding interactions has been discovered in the nucleus when the polymer/DNA 
complexes were delivered to mammalian cells [51, 52].  Systematic injection of 
polyplexes may have been subject to similar premature unpacking due to the interactions 
with serum proteins or components of ECM, and the theory has been shown in vitro [53, 
54]. 
To prevent the undesired interactions with serum proteins or ECM, shielding of 
polyplex surface charge is essential in the design of polymeric cationic gene carriers. One 
of the common approaches involves grafting of non-ionic, flexible hydrophilic polymers 
such as poly(ethylene glycol) (PEG) and poly[N-(2-hydoxypropyl)methacrylamide] 
(PHPMA) [55]. These polymers can effectively suppress the access and adsorption of 
biomacromolecules due to the excluded volume effect by the highly flexible and hydrated 
chains. The grafting of the PEG chain onto a polymer is termed PEGylation, and PEG has 
been shown to substantially prevent the aggregation or destabilization of polyplexes 
induced by serum proteins [56, 57]. Nomoto and colleagues used real-time confocal laser 
scanning microscope to observe the aggregate formation of polyplexes and confirmed 
that polyplexes formed aggregates quickly after intravenous injection [58].  
Storm and colleagues have proposed a theory to explain the apparent protein 
shielding effect imparted to polymers when PEG chains are grafted [59]. Their theory 
  8 
suggested that the surface PEG chains existed in a more extended conformation when 
free in solution due to their hydrophilic and flexible nature. When interacting with a 
serum protein, the van der Waals force is created due to the attraction between the protein 
and the PEG chain. The PEG chain is subsequently compressed, forcing the PEG chain 
into a more condensed configuration and generating an opposing force that tries to 
balance the attractive force between the negatively charged serum protein and the 
positively charged polymer chain. Therefore the PEG chain length and the grafting 
density are two key factors in the design of PEGylated polymer and they could influence 
the pharmacokinetic properties of the polyplexes [60]. However, in vivo studies reported 
in literature present controversial results. Some groups reported that a low graft density 
with a long PEG chain is more effective[61], and others found the grafting density is 
more dominant than PEG chain length[62]. A better understanding of the effect of 
PEGylation and PEG chain length on the in vivo physiological and biological properties 
of the nanocomplexes is essential to provide insight for the design of a more efficient 
gene carrier. 
 
1.5 Thesis overview 
 
In order to have a rational design for cationic polymer based gene carrier, it is 
critical to understand the rate limiting factors in the process. Two major challenges faced 
by polyplex-mediated gene delivery that prevent its wide application in clinical trials are 
its low transfection efficiency and its high cytotoxicity. Three pathways of cytotoxicity 
include apoptosis, necrosis and autophagy. Apoptosis and necrosis have been extensively 
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studied by researchers, but autophagy is only recently recognized as a pathway of cell 
death. In Chapter 2, we investigated autophagy induction by PEI/DNA polyplexes in 
murine fibroblasts using three different methods: transmission electron microscopy 
(TEM), immunofluorescence staining and Western blotting. We successfully decoupled 
polyplex-induced autophagy from apoptosis and necrosis and evaluated the influence of 
autophagy on polyplex-mediated transgene expression using small molecules known to 
inhibit or induce autophagy.  
To improve transfection efficiency, many researchers have adjusted the structure 
of the polymer gene carriers to optimize the transgene expression in vitro. However, in 
vitro results often provide poor indication to in vivo conditions. To understand the in vivo 
performance of polymer based gene carrier in Chapter 3, we used 2 series of poly(2-
aminoethyl methacrylate) (PAEM) polymers with well defined chain length and narrow 
molecular weight distribution to conduct a comprehensive investigation of colloidal 
properties of PAEM/DNA or PEG-PAEM/DNA polyplexes.  Particle size, surface 
charge, polyplex stability in vitro and in vivo transfection, as well as local biodistribution 
were carefully examined to further elucidate the impact of polymer chain length, 
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Chapter 2: Modulating polyplex-mediated gene transfection by 
small molecule regulators of autophagy  
2.1 Introduction 
A major challenge in the development of polymeric gene delivery carrier is to 
achieve high transfection efficiency with minimal cytotoxicity. Unfortunately, many 
cationic polymer gene carriers are often cytotoxic, thereby limiting their gene transfection 
efficiency. For example, polyethylenimine (PEI) is one of the most widely investigated 
cationic gene carriers with generally good transfection efficiency in many cell types [15, 
63-65]. However, PEI (especially the highly branched form) is also well-known for its 
substantial cytotoxicity that prohibits its application in humans [66]. Previous work, 
including ours, has shown that depending on the dose of the polyplex, PEI-mediated gene 
transfer induces apoptosis and necrosis in many cell types and that polyplex-induced cell 
death compromises transgene expression [3, 22, 24, 67, 68]. Various chemical 
modifications of PEI and a great variety of other cationic polymers have been evaluated 
that showed low cytotoxicity [22, 24, 69], but a thorough understanding of the 
relationship between cellular stress responses and polyplex-mediated transfection is still 
lacking. 
There are three major modes of response by cells under stress: apoptosis, necrosis 
and autophagy [26]. Unlike apoptosis, autophagy (or “self-eating”) is often considered a 
cell survival mechanism through removing damaged proteins and subcellular organelles, 
so as to cope with stressful conditions such as starvation and chemical or biological 
assaults [70-72]. The process starts with the formation of isolation membrane, a 
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subcellular single-membrane structure, enclosing the proteins and organelles that are 
targeted for degradation. When the isolation membrane completely surrounds the 
cytoplasmic materials, a double-membrane autophagosome is formed. During the 
formation of autophagosome, a cytoplasmic protein, LC3 I, becomes covalently linked to 
phosphatidylethanolamine (PE), giving rise to LC3 II, which then associates with both 
the inner and outer membranes of the autophagosome. Subsequently, autophagosome 
fuses with lysosome to degrade the sequestered content, releasing amino acids for 
recycle. Thus, autophagy can function as a mode of stress adaptation to avoid cell death. 
However, if the stress is too severe or prolonged, autophagy can lead to cell death. 
Autophagy can be activated and regulated by physiological and pathological stimuli 
including starvation [42], intracellular viruses and bacteria [43], and nanomaterials such 
as calcium phosphate precipitates[44], quantum dots[45] and gold nanoparticles[46].  
Induced autophagy has also been observed in certain cell types exposed to various 
cationic molecules alone such as polyamidoamine (PAMAM) in human lung A549 
cells[47], PEI in nephritic and hepatic cells[48] and cationic lipids in a HeLa cell 
line[41], and more recently, lipoplexes and polyplexes in several types of primary cells 
and cell lines [73, 74]. However, because there is much crosstalk between autophagy and 
apoptosis [75], it is not yet clear if polyplexes could activate autophagy directly without 
inducing apoptosis and vice versa. Furthermore, how autophagy activation might affect 
polyplex-mediated gene transfection is not well understood, although recent studies on 
polyplex intracellular trafficking[73]  and transfection of genetically modified atg5
-/-
 cells 
[74] imply that autophagy might hinder nonviral gene transfer.  
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In this study, we investigated autophagy induction by PEI/DNA polyplex in murine 
fibroblasts and attempted to (1) decouple polyplex-induced autophagy from apoptosis and 
necrosis, and (2) modulate polyplex-mediated gene transfection using small-molecule 
regulators of autophagy. We hope that this work could contribute to better mechanistic 
understanding of polyplex-induced cytotoxicity and to establish the feasibility of 
enhancing nonviral gene delivery through manipulating autophagy. 
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2.2 Experimental Methods 
2.2.1 PEI/DNA polyplexes preparation 
PEI (branched, 25 kDa, Sigma) and plasmid DNA stock solutions, both at 
concentration 1 mg/mL, were diluted to 0.1 mg/mL in 20 mM HEPES buffer (pH7.4). 
Polyplexes were prepared at an N/P ratio of 8 by vortex mixing equal concentrations of 
PEI and plasmid DNA in 20 mM HEPES buffer to a total volume of 100 µL, and allowed 
to incubate at room temperature for 30 min. To study autophagy induction by PEI/DNA 
polyplexes, a plasmid encoding the luciferase gene (pCMV-Luc, Elim 
Biopharmaceuticals) was used to prepare polyplexes. A plasmid encoding enhanced 
green fluorescence protein (GFP) (pEGFP-N1, Elim Biopharmaceuticals) was used to 
investigate the effect of autophagy on transfection efficiency.  
2.2.2 Cell culture and transfection 
NIH 3T3 murine fibroblasts (ATCC) were cultured in DMEM (1 g/L D-glucose, L-
glutamine, 110 mg/L sodium pyruvate, Gibco) supplemented with 10% fetal bovine 
serum (heat inactivated, Gibco) and 100 units/mL penicillin/streptomycin (Gibco). 
NIH 3T3 cells were plated at 5×10
4
 per well in 12-well plates and allowed to adhere 
overnight. After washing with phosphate buffered saline (PBS, pH7.4), the cell media 
was replaced with serum free media and polyplexes were added to the cells, incubated for 
4 h. The final concentrations of the plasmid, PEI, and polyplex were 2, 2.8, and 4.8 
μg/mL, respectively. The cells were then washed three times with PBS before replacing 
the serum free media back to regular cell media with 10% serum. Twenty-four hours after 
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the initial addition of polyplexes, cells were washed with PBS, trypsinized, suspended in 
in FACS buffer (containing 1% bovine serum albumin, BSA, and 1 mM sodium azide in 
PBS) and analyzed by flow cytometry using LSR II flow cytometer (Becton Dickson) 
and FlowJo software. Cells transfected with luciferase encoding DNA were used as the 
control for any increased autofluorescence of cells caused by polyplexes nonspecifically. 
GFP-positive cells were gated against the luciferase transfected control cells. 
To investigate the role of autophagy on transgene expression and apoptosis/necrosis, 
autophagy inhibitor 3-methyladenine (3-MA, Sigma) was incubated with the cells at a 
concentration of 10 mM during the 4 h transfection. Autophagy enhancer rapamycin 
(Rapa, Calbiochem) was given to the cells 2 h before transfection and again 4 h after the 
initial addition of polyplexes at a concentration of 100 nM and prepared as fresh solution 
again. 
2.2.3 Transmission Electron Microscopy (TEM) 
Twenty-four hours after the initial addition of polyplexes, cells were harvested by 
trypsinization, washed in 0.1 M sodium cacodylate buffer (pH 7.2), pelleted by 
centrifugation, fixed in 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer for 1 h, 
and post-fixed in 1% osmium tetroxide in 0.1 M sodium cacodylate buffer for another 1 
h. After dehydration with graded ethanol and propylene oxide, cells were embedded in 
Epon resin (Polysciences). Ultra-thin sections of 65 nm were cut with a microtome, 
stained with 8% uranyl acetate and lead citrate and examined using JEOL 1200 EXII 
transmission electron microscope. 
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2.2.4 Immunofluorescence staining and microscopy 
NIH 3T3 cells were plated on chamber slides, prepared and treated the same way as 
described above in Section 2.2. Twenty-four hours after the initial addition of polyplexes, 
cells were washed with PBS, fixed by Cytofix for 10 min and permeabilized in 0.2% 
Triton x-100 in PBS for 10 min. After blocking in 5% normal donkey serum (Jackson 
Immune) for 1 h at room temperature, the cells were incubated with 1:250 diluted rabbit 
anti-LC3 antibody (Novus Biologicals) for 1 h, followed with 1:500 diluted FITC-
conjugated donkey anti-rabbit secondary antibody (Novus Biologicals) for 1 h. The cells 
were counter stained with Hoechst 33342 and visualized using an Olympus IX70 inverted 
microscope equipped with a standard FITC/TRITC/DAPI filter set, Olympus DP72 
camera, and CellSens software. Five fields of view were taken for each sample. The total 
number of cells in each field of view was determined based on Hoechst nuclei staining. 
The number of cells with at least one autophagosome stained were counted in each field 
of view and used to calculate the percentage of cells with autophagosomes as a 
quantitative measure of autophagy. 
2.2.5 Western Blot 
Twenty-four hours after the initial addition of polyplexes, cells were harvested by 
trypsinization and lysed in 1% nonidet-P40 containing 1 mg/mL aprotinin (Sigma), 1 
mg/mL leupeptin (Sigma) and 1mg/mL pepstatin A (Sigma). The cell lysates were 
separated by 8%-16% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) and transferred to a nitrocellulose membrane at 200 mA, 4ºC for 45 min and β-
actin was used as an internal loading control. The membrane was blotted with 5% non-fat 
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dry milk in PBS containing 0.1% Tween 20 for 1 h at room temperature. Following the 
application of the primary rabbit anti-LC3 (1:1000 diluted, Novus Biologicals) or mouse 
anti-β-actin (1:3000 diluted, Sigma) antibody for 1 h, the blot was incubated with 
horseradish peroxidase (HRP)-conjugated donkey anti-rabbit or goat anti-mouse 
secondary antibody (1:5000 diluted, Amersham) for 1 h and developed using 
chemiluminescent substrates. The relative intensity of each band was determined using 
the gel analyzer function in ImageJ software. 
2.2.6 Apoptosis/necrosis assay 
Twenty-four hours after the transfection, cells were harvested by trypsinization, 
washed with 300 µL of Annexin V staining buffer (BioLegend) and resuspended in 100 
µL of Annexin V staining buffer before they were stained with Alexa Fluor 647-labelled 
Annexin V (BioLegend) and propidium iodide (PI, BioLegend). The cells were then 
analyzed by flow cytometry using LSR II flow cytometer (Becton Dickson) and FlowJo 
software. 
 
2.2.7 Analysis of Reactive Oxygen Species (ROS) 
NIH3T3 cells were plated at 5 × 10
4
 per well in 96-well plates and treated the 
same way as described above in Section 2.2. Four or twenty-four hours after the initial 
transfection, 40 µM of 2’,7’-dichlorodihydrogluorescein diacetate (DCFH-DA, Signam-
Aldrich) was added to the cells and incubated for 20 min at 37 ºC. The fluorescent signal 
was detected using a plate reader (Bio-Tek) with excitation at 485 nm and emission at 
528 nm. 
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2.2.8 Cellular uptake and subcellular trafficking 
To understand how polyplexes interact with fibroblasts during autophagy, cellular 
uptake and subcellular trafficking were studied as described in a previously published 
paper from our group[76]. Briefly, NIH3T3 cells were plated on chamber slides and 
treated the same way as described in Section 2.2. Cy5 fluorophore labeled luciferase 
plasmid was used in transfection. Thirty minutes before imaging, Hoechst 33342 
(Invitrogen) was added to each chamber at a final concentration of 30 µM followed by 
LysoTracker Green DND-26 at a final concentration of 100 nM. The cells were then 
washed with PBS and mounted with 5 µM of ascorbic acid to minimize photobleaching. 
Cell images were captured using an Olypus FC-1000 confocal microscope equipped with 
an Olympus 60x/1.42 NA oil-immersion lens (Center Valley) and analyzed using Image J 
software following the protocols described in the published paper. 
2.2.9 Statistical analysis 
Comparisons between groups were made using Student’s t-test. A p-value of less 
than 0.05 was considered to be statistically significant. All results were presented as 
mean ± standard deviation (SD) except that of the nuclear localization studies, which was 
presented as mean ± standard error (SE). 
  18 
2.3 Results 
2.3.1 Physical characterization of PEI/DNA polyplexes 
PEI/DNA complexes were prepared at an N/P ratio of 8. The average 
hydrodynamic diameter of the polyplexes measured by dynamic light scattering was 
116.6 + 0.964 nm and the average zeta potential was +36.06 + 2.77 mV. The morphology 
of the complexes was captured by TEM and the images showed globular particles with a 
roughly uniform size distribution (Fig. 1). 
 






Fig. 1. Physical characterization of PEI/DNA polyplexes prepared at N/P ratio of 8. (A) 
A representative TEM image of PEI/DNA complexes at N/P ratio of 8. 
 
A 
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2.3.2 Transfection by PEI/DNA polyplexes induced early autophagy in fibroblasts 
The most traditional method for identifying autophagy is electron microscopy, and 
indeed, autophagy in mammalian cells was first discovered by this method[77, 78]. TEM 
reveals the presence of autophagosomes based on their unique morphology as double-
membrane vesicles containing cytoplasmic materials or organelles such as the 
endoplasmic reticulum, mitochondria, and ribosomes. The diameter of autophagosomes 
in cultured cells usually averaged about 600 nm. Here TEM analysis showed that the 
majority of polyplexes transfected fibroblasts contained one or more double-membrane 
autophagosomes filled with cytoplasmic materials, whereas very few untreated cells had 
any autophagosomes (Fig. 2), indicating that exposure to PEI/DNA polyplexes induced 
early autophagy in fibroblasts.  
The presence and subcellular distribution of the autophagy marker LC3 was validated 
and quantified by intracellular immunofluorescence staining with an anti-LC3 antibody 
followed by fluorescence microscopy. We observed that LC3 II was present in the 
untreated fibroblasts and localized to the autophagosomes as distinct puncta (Fig. 3A), 
which is typical for cells undergoing autophagy [25, 26]. The average fraction of 
polyplex-transfected cells containing at least one autophagosome was approximately 
30%, significantly higher than untreated cells with basal autophagy (around 5%) (Fig. 
3B). When transfected cells were treated the autophagy inhibitor 3-MA, the average 
fraction of autophagic cells was reduced to slightly below 20%, whereas treatment with 
the autophagy inducer rapamycin increased it to nearly 50% (Fig. 3). Treatment with PEI 
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alone also resulted in the formation of the characteristic LC3 puncta in fibroblasts, 
although at a slightly lower level than the fibroblasts treated with polyplexes (Fig. 4).  
The two subtypes of LC3 proteins (I and II) were detected and quantified through 
analyzing the cell lysates by Western blot. Relative to the cytoplasmic LC3 I, the 
autophagosomal LC3 II was detected at low amounts in untreated cells but was at much 
higher levels in polyplex-transfected cells (Fig. 5A). The band intensity ratio of LC3 II 
over β-actin is known to highly correlate with the number of autophagosomes[79]. 
Therefore, LC3 II/β-actin ratio was much higher for polyplex-transfected cells than 
untreated cells (Fig. 5B), indicative of polyplex-induced autophagy. Treatment with 3-
MA or rapamycin reduced or increased the relative expression of LC3 II in transfected 
cells (Fig. 5), suggesting less or more autophagy induction, which agrees well with the 
findings by LC3 immunofluorescence microscopy (Fig. 3). 
 
 













Fig. 2. Representative TEM images of the cytoplasm of untreated and PEI/DNA polyplex 
transfected fibroblasts, showing autophagosomes with distinct double-membrane 
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Fig. 3. PEI/DNA polyplex transfection resulted in LC3 puncta formation in fibroblasts. 
(A) A set of representative images of LC3 immunofluorescence staining in fibroblasts 
that were either untreated, transfected with polyplexes, or transfected in the presence of 
10 mM 3-MA or 100 nM Rapa. Scale bar: 50 µm. (B) Quantification of LC3 puncta 




















Fig. 4. PEI/DNA polyplex transfection resulted in LC3 puncta formation in fibroblasts. 
(A) A set of representative images of LC3 immunofluorescence staining in fibroblasts 
that was either untreated, transfected with polyplexes, or transfected in the presence of 
PEI only. Scale bar: 50 µm. (B) Quantification of LC3 puncta (representing 
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Fig. 5. Western blot of LC3 isoforms. (A) A representative blot of fibroblasts that were 
either untreated, transfected with polyplexes, transfected in the presence of 10 mM 3-MA 
or 100 nM Rapamycin. (B) Densitometry analysis of the ratio of band intensities between 
LC3 II and β-actin. The bar graph represented the average of three independent 
experiments with standard deviations. 
 B 
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2.3.3 Modulation of polyplex-induced autophagy in fibroblasts did not affect 
cytotoxicity due to apoptosis or necrosis 
To decouple cytotoxicity due to autophagy from other pathways of cell death, we 
monitored the changes in apoptosis and necrosis by staining cells with Annexin V and PI 
after autophagy modulators were applied during transfection with polyplexes. Comparing 
to untreated cells, there was only minor cytotoxicity (~5.5%) due to apoptosis and 
necrosis in fibroblasts after transfection with PEI/DNA complexes at N:P ratio of 8 (Fig. 
6), which is consistent with our previous findings [31]. Moreover, the addition of 
autophagy modulators, 3-MA (10 mM) or rapamycin (100 nM), did not change the 
percentage of apoptotic and necrotic cells significantly comparing to cells exposed to 
polyplexes without the autophagy modulators (Fig. 6). 
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Fig. 6. Modulation of polyplex-induced autophagy in fibroblasts did not affect 
cytotoxicity due to apoptosis or necrosis. (A) A representative set of dot plots of 
apoptotic and necrotic cells by flow cytometry after staining with Annexin V and PI. (B) 
Quantification of apoptosis and necrosis. The bar graph represented the average of 
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2.3.4. Transfection efficiency was positively correlated with polyplex-induced 
autophagy in fibroblasts 
It has been shown in the previous section that the selected drug concentrations and 
treatment schemes did not aggravate apoptosis or necrosis. To examine the effect of 
modulating autophagy on transfection efficiency, we determined GFP transgene 
expression level in fibroblasts with treatment of 10 mM 3-MA or 100 nM rapamycin. 
After normalizing transfection efficiency against the polyplex only group (Fig.7), we 
found 3-MA reduced the fraction of GFP
+
 cells by 80%, but the addition of rapamycin 
increased the percentage of GFP
+
 cells by approximately 27% (Fig. 7). The 
corresponding reduction and increment in MFI of all cells was >90% and ~100%, 
respectively (Fig. 7). These results established a positive correlation between transfection 
efficiency and polyplex-induced autophagy. We further tested the effect of different 
doses of 3-MA and Rapa on gene transfection and the results are shown in Fig. 8. It is 
clear that with increasing dose of 3-MA, transfection efficiency decreased. Transfection 
was enhanced in the presence of 50 and 100 nM Rapa and no further enhancement was 
seen at 1000 nM. These results established a robust, positive correlation between 
transfection efficiency and autophagy modulation. 
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Fig. 7. Inhibition of polyplex-induced early autophagy decreased GFP transgene 
expression while promoting autophagy increased GFP transgene expression. (A) A 
representative set of dot plots of flow cytometry showing GFP
+
 cells. (B) Quantification 
of transfection efficiency, either as percent of GFP+ cells or as mean fluorescence 
intensity (MFI), then normalized against that of the polyplex-transfected cells without 


























Fig. 8. Dose dependence of 3-MA/Rapa treatments on transfection efficiency. * p<0.05, 
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2.3.5 Transfection of PEI/DNA polyplexes elevated the level of intracellular ROS 
but modulating autophagy does not affect the ROS production 
Intracellular ROS was probed with DCFH-DA 4 h and 24 h after the initial 
transfection with or without autophagy modulators. Early on during transfection (4 h), 
there was no significant difference in the intracellular ROS level between the untreated 
and polyplexes treated cells (Fig. 9). Although there is no statistically significant 
difference, the 3-MA treated cells had slightly higher ROS level than the polyplexes only 
group, and the rapamycin treated cells had slightly lower ROS level than the polyplexes 
only group. Twenty-four hours after the transfection, all three polyplexes treated groups 
showed a slight but significantly higher ROS production than the untreated group. 
However, the 3-MA or the rapamycin treated cells did not show any significant 
difference in ROS compared to the polyplexes only group (Fig. 9). 
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2.3.6 Autophagy regulation affected cellular uptake and subcellular trafficking 
Polyplex containing Cy5-labeld luciferase plasmid was used to visualize nuclear 
localization by confocal fluorescence microscopy 4 h and 24 h after transfection. The 
efficiency of nuclear entry by the plasmid was quantified by the total fluorescence 
intensity of Cy5 signal inside the nucleus (Fig. 10). There were expected increases in 
nuclear localization from 4 h to 24 h across all the groups. At 4 h there was less amount 
of plasmid localizing in the nuclei of cell treated with 3-MA and rapamycin than cells 
without these treatments. By 24 h, nuclear localization in 3-MA treated cells was still 
lower, but rapamycin treatment led to a significant higher nuclear uptake of plasmid (Fig. 
10).   
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Fig. 10. Nuclear uptake of plasmid DNA delivered as polyplexes with or without 
treatment of 3-MA (10 mM) or Rapa (100 nM). Quantification of (A) nuclear uptake was 
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2.4 Discussion 
While autophagy, as an important form of cell stress response and cell death pathway, has 
long been established, it is only in recent years that nanomaterial-induced autophagy has 
been reported [41, 47, 48]. In this study, we demonstrated that transfecting fibroblasts 
with PEI/DNA polyplex led to the induction of autophagy using three different common 
techniques. By TEM analysis, autophagosomes are identified as characteristic double-
membrane vacuoles containing cytoplasmic materials [77, 80]. Double-membrane 
autophagosomes were clearly observed in TEM images of fibroblasts treated with 
polyplex (Fig. 2). Further quantification using biochemical assays of LC3 confirmed our 
observation by TEM. Immunofluorescence staining of LC3 revealed the redistribution of 
LC3 from cytosolic soluble form (LC3 I) to the membrane-bound form (LC3 II), 
indicating the formation of autophagosomes (Fig. 3A). The conversion of LC3 I to LC3 II 
was also quantified by Western blot (Fig. 5). Taken together, these pieces of evidence 
strongly suggest that PEI/DNA polyplex transfection induced autophagy in fibroblasts, 
which is consistent with observations made by other groups different cell types and other 
cationic polymers [41, 47, 48, 73, 74, 81]. We also compared autophagy induction by PEI 
polymer alone with PEI/DNA polyplex at the same dose (Fig. 4), and the results suggest 
that the nanoparticulate form of the polyplex might be more potent in autophagy 
induction than the free polymer alone. This could be due to differences in positive charge 
density and particle size between the free polymer and the nanoparticulate polyplex.  
The mechanism of autophagy induction by nanoparticles of diverse compositions is not 
clearly understood. An important mediator is likely to be reactive oxygen species (ROS). 
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First, ROS generation and oxidative stress are often found in different types of cells upon 
exposure to a variety of nanoparticles such as gold, silica, titanium oxide, iron oxide, 
lipoplexes, and polyplexes [46, 82, 83]. Intracellular ROS can oxidize genomic DNA, 
cellular proteins and lipids [84], resulting in breakage of DNA strands and accumulation 
of damaged proteins in the ER lumen that could eventually lead to cell death. Second, 
elevated ROS level is known to trigger autophagy to alleviate ROS-induced cytotoxicity 
through clearing damaged molecules and subcellular structures [85-88]. Therefore, we 
postulate that polyplex-induced autophagy in fibroblasts that we observed here may be 
related to the intracellular ROS production triggered by exposure to the PEI/DNA 
polyplex as well as free PEI chains. Compared to untreated cells, we have indeed 
detected a slightly higher level of ROS in polyplex treated cells that underwent 
autophagy (Fig. 8). Thus, our observation reinforces the possibility that the intracellular 
ROS production may play a role in polyplex-induced autophagy. 
What is the impact of autophagy on polyplex-mediated gene delivery? To address this 
question, one must first decouple the potential effect due to autophagy from that due to 
apoptosis and necrosis. It is well established that autophagy and apoptosis share a 
complex functional relationship with each other, that is, inhibiting one often aggravates 
the other [75]. For example, when autophagy was inhibited in sulindac sulfide treated 
HT-29 colon carcinoma cells, apoptosis in these cells was enhanced [89]. On the other 
hand, suppressing apoptosis could activate autophagy in mouse fibroblasts or 
macrophages [90]. Previous work from our lab
7
 and others [3, 24, 66, 68] has also shown 
that polyplex transfection induces apoptosis and necrosis. Here we took two measures to 
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ensure that the functional consequence of autophagy was examined and modulated 
without the interference from apoptosis. First, the dose and N:P ratio of PEI/DNA 
polyplex for transfection were chosen as such that apoptosis and necrosis due to polyplex 
treatment was minimized (Fig. 6). Second, the dosages of autophagy modulators (3-MA 
and rapamycin) and the time course of treatment were optimized so that they could 
effectively inhibit or activate autophagy (Fig. 3 & 4) without causing additional apoptotic 
or necrotic response (Fig. 6). 
Interestingly, we found that inhibiting autophagy with 3-MA during polyplex-mediated 
gene delivery reduced transfection efficiency, whereas further activating autophagy using 
rapamycin increased transgene expression (Fig. 7). Attempting to explain our 
observation, we first consider the potential role of oxidative stress. Elevated level of 
intracellular ROS is known to correlate strongly with cytotoxicity of cationic polymers 
such as PEI in a number of cell types [91, 92]. It is also known that reducing oxidative 
damage through lowering intracellular ROS level could improve cell survival and 
enhance transfection efficiency [91, 92]. Thus, it might be possible that inhibiting or 
activating autophagy led to aggravation or relief of oxidative stress, thereby impairing or 
enhancing transfection. However, we found that treatment with 3-MA or rapamycin did 
not cause any significant change in intracellular ROS level (Fig. 8), suggesting that 
oxidative stress was not the reason for the observed changes in transfection efficiency. 
We then considered the possible scenario that autophagy modulation somehow altered 
the subcellular trafficking process of the polyplex. To achieve transgene expression, the 
polyplex must traverse several intracellular barriers to deliver the plasmid DNA into the 
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cell nucleus [93-95]. We found that nuclear localization of plasmid DNA was reduced in 
3-MA-treated cells but was enhanced in rapamycin-treated cells (Fig. 10), which 
correlated well with the reduction and enhancement of transfection efficiency (Fig. 6). It 
was reported that some polyplex inside autophagosome was found in the perinuclear 
region[74]. In our case, the PEI/DNA polyplex escaping autophagosome in the vicinity of 
the nucleus would have a higher probability of entering the nucleus via a shorter path, 
which could be a plausible explanation for the observed increase in nuclear translocation 
of plasmid and transfection efficiency. Whatever the mechanism may be, it is certain that 
subcellular trafficking of polyplex must play a pivotal role in determining how autophagy 
modulation impacts gene delivery.  
Two outstanding challenges require future investigation. The first challenge is to 
understand if selecting different molecular targets for autophagy modulation could impact 
gene delivery in different ways. Recently Roberts et al [74]reported that polyplex 
consisting of a proprietary polymer (JetPRIME, composition unknown) and plasmid 
DNA was endocytosed and localized in tubulovesicular autophagosomes (TVAs) of cells. 
They further showed that when TVA formation was disabled in atg5 knockout cells, 
polyplex-mediated gene transfection was compromised, suggesting that autophagy could 
be a barrier for gene delivery. Numerous factors could account for the disparate 
conclusions of Roberts et al
  
[74]and our study. There are major differences in the type of 
polyplex and cells used, time course/medium/dosage of transfection, and in particular, 
selection of molecular target for autophagy modulation. TVA, a special form of 
autophagosome, is formed through a noncanonical pathway of autophagy independent of 
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class III phosphatidylinositol 3-kinase (PIK3C3) but dependent on ATG5[74]. However, 
the small-molecule autophagy modulators used in this study target the canonical pathway 
of autophagy with 3-MA inhibiting phosphatidylinositol 3-kinase (PI3K) and rapamycin 
inhibiting mTOR [96]. Thus, targeting different molecules and pathways of autophagy 
does seem to produce different functional outcome in gene delivery. The second 
challenge is to gain comprehensive understanding of how autophagy modulation alters 
the subcellular trafficking pathways of polyplex. Autophagy activation and inhibition 
could potentially impact endocytic uptake, autophagosomal localization, and nuclear 
transport of polyplex. Previous studies suggest that entrapment inside autophagosome 
could be a hurdle for gene delivery [73, 74], but on the other hand, transportation of 
autophagosome-entrapped cargo to the perinuclear region[74] might actually increase the 
chance of delivery into the nucleus and enhance transgene expression. Our results here 
further indicate that small-molecule modulators of autophagy could either facilitate or 
hinder nuclear delivery of plasmid DNA. Visualization and quantitative assessment of 
subcellular trafficking of polyplex in autophagic cells will help identify rate-limiting 
steps of delivery and offer better strategies to overcome them. Amidst the growing 
interest in targeting autophagy for therapeutic purposes[97], this work advocate the 
possibility of enhancing the efficiency of nonviral gene delivery through autophagy 
modulation. It is envisioned that this approach could be carried out by co-delivery of 
small-molecule autophagy modulators [98] and therapeutic genes using appropriately 
designed dual functional polymeric carriers.  
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Fig. 11.  A schematic summary of proposed intracellular trafficking pathway 
involving autophagy. Polyplex is taken up by cell through endocytosis (1). Some of the 
polyplexes can escape endosome (2) and enter cytoplasm. Other polyplexes remained in 
endosome and were delivered to lysosome for degradation when the endosome was fused 
with lysosome (3). Two possible fates could happen to the polyplexes free in the 
cytoplasm. They can swim towards the nucleus and enter the nucleus undisturbed (4), or 
some of them will be encapsulated by autophagosome on their way to the nucleus (5). 
Some of the autophagosomes may swim towards the nucleus, bring the polyplexes closer 
to the nucleus. Other autophagosomes may engulf endosomes that are loaded with 
polyplexes, preventing them from fusing with lysosome and therefore protecting 
polyplexes from lysosomal degradation. 
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To the best of our knowledge, this is the first study reporting that the induced autophagy 
plays an important role in regulating gene transfection efficiency. While  an earlier work 
has reported that PEI-induced autophagy contributed to cell death [48], our study reveals 
that autophagy has a significantly positive impact on polyplex-mediated gene transfer. 
Our findings suggest that promoting autophagy may be a useful approach to augment 
polymer-mediated gene delivery. Conceivably, this could be accomplished through 
adjusting the dose of the polyplex and co-delivery of autophagy inducers or apoptosis 
inhibitors with the polyplex.  
2.5 Conclusions 
Transfection of mouse fibroblasts using appropriately formulated PEI/DNA polyplex 
activated early autophagy with only minimal apoptotic or necrotic cytotoxicity. Polyplex-
induced autophagy was confirmed by visualization of double-membraned 
autophagosome, intracellular aggregation of LC3 indicative of autophagosome formation, 
and quantification of autophagosome-associated LC3 II protein. Treating polyplex-
transfected cells with autophagy-inhibiting 3-MA reduced transfection efficiency, 
whereas cells treated with autophagy-activating rapamycin resulted in enhancement of 
transgene expression. Treatment by these small-molecule modulators of autophagy did 
not cause any additional apoptosis or necrosis in cells, thus allowing decoupling the 
functional consequence of autophagy from that of other modes of cellular stress response. 
Autophagy modulation had no impact on oxidative stress imposed by the polyplex but 
did alter significantly the amount of plasmid DNA localized to the cell nucleus, 
implicating subcellular trafficking as an important factor in determining how autophagy 
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affects gene delivery. These findings advocate a new strategy of enhancing polyplex-
mediated gene transfection efficiency by small-molecule regulators of autophagy. 
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Chapter 3: Structure-function Relationship of Well-defined 
Polymeric Gene Carriers: Comparison of in vitro Properties 
with in vivo Performance 
3.1 Introduction 
Gene therapy holds great potential to enhance human medicine since it can 
potentially treat a variety of genetic disorders or cancers[12]. The goal is to deliver a 
sufficient amount of DNA to produce a therapeutic level of protein which in turn can 
alleviate the phenotypes of the disease. Many viral vectors have been used to deliver the 
genetic materials since they often provide a high delivery efficiency[10]. However, they 
pose safety concerns since they can provoke severe immune response in the host, leading 
to fatalities[99]. Non-viral vectors provides a synthetic alternative to the problem and 
possess the potential advantages of low immunogenicity and easy of synthesis[15]. The 
hurdle with non-viral vectors remains in the low delivery efficiency, and it is critical to 
develop safe and effective non-viral vector to bring the eventual success of gene therapy. 
Polycationic polymers have been widely investigated as gene livery carrier 
because of their versatility. Physical properties such as polymer molecular weight or 
chain length and surface characteristics are important factors in the design of polycationic 
polymer based gene carriers, and they can be tuned to modulate gene delivery properties 
including DNA binding, colloidal stability of the complex, endosomal escape, 
cytotoxicity and transfection efficiency. 
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Molecular weight or polymer chain length plays a key role affecting transfection 
efficiency. Hennink and colleagues reported that the molecular weight of poly(2-
dimethylaminoethyl methacrylate) (PDMAEMA) significantly affected transfection 
efficiency, and a higher molecular weight favored the high transfection efficiency[17]. 
Mikos and colleagues determined that the higher molecular weight PEI transfected better 
than the lower molecular weight PEI[18]. In general, a higher molecular weight is in 
favor of a high gene expression, but some discrepancies existed[19]. A fundamental 
understanding of the effect of linear polycation chain length on the gene delivery process, 
especially in the in vivo environment remains elusive. 
The in vivo efficiency of the polyplex delivery system depends on its ability to 
overcome both the extracellular and intracellular hurdles. The extracellular barriers 
involve serum proteins and components of the extracellular matrix (ECM), a large 
proportion of which are negatively charged[49]. The negative charge interacts with the 
positive charge of the surface of the polyplexes, leading to complex dissociation or 
aggregation. To limit non-specific protein binding and mask the net positive charge, 
poly(ethylene glycol) (PEG) is often grafted to the surface of the complex, and 
PEGylation has been reported to be a very effective way to attenuate the positive surface 
charge and improve polyplex stability under physiological salt and serum condition[56, 
57]. Both PEG chain length and grafting density could influence the pharmacokinetic 
properties of the polyplexes[100], however, in vivo studies reported in literature have 
controversial results. Some groups reported that a low graft density with a long PEG 
chain is more effective[61], and others found the grafting density is more dominant than 
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PEG chain length[62]. A better understanding of the effect of PEGylation and PEG chain 
length on the in vivo physiological and biological properties of the nanocomplexes is 
essential to provide insight for the design of a more efficient gene carrier. 
In this study, we used 2 series of poly(2-aminoethyl methacrylate) (PAEM) 
polymers with well-defined chain length and narrow molecular weight distribution to 
conduct a comprehensive investigation of colloidal properties of PAEM/DNA or PEG-
PAEM/DNA polyplexes.  Particle size, surface charge, polyplex stability in vitro and in 
vivo transfection, as well as local biodistribution were carefully examined to further 
elucidate the impact of polymer chain length, PEGylation and PEG chain length on gene 
carrier design.  
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3.2 Experimental Methods 
3.2.1 Dynamic Light Scattering and Zeta Potential Measurement 
The average hydrodynamic diameter and polydispersity index of polyplexes in 
HEPES buffer (20 mM) at 25 °C were determined using a ZetaPlus particle analyzer 
(Brookhaven Instruments Corp., Holtsville, NY; 27 mW laser; 658 nm incident beam, 
90° scattering angle). Polyplexes with N/P ratios ranging from ½ to 16 were prepared by 
adding 25 µL of polymer solution in 20 mM HEPES (pH 7.4) to 25 µL of DNA plasmid 
solution (0.2 µg/µL in 20 mM HEPES, pH 7.4), vortexed for 10 s, and incubated for 30 
min at room temperature. The polyplex solutions were diluted 20 times to a final volume 
of 2 mL in HEPES buffer before measurement. Simultaneously, the zeta potential of the 
polyplexes was determined using the ZetaPal module of the particle analyzer. 
3.2.2 Gel Retardation Assay 
Polyplexes of N/P ratios ranging from 1/8 to 16 were prepared as described above 
and analyzed by electrophoresis on a 1.0% agarose gel containing 0.5 µg/mL ethidium 
bromide.  
3.2.3 Heparin Competition Assay 
To determine the strength of DNA binding by polymers with varying chain 
length, polyplexes at N/P ratio of 8 were incubated with increasing concentrations of 
heparin (0.1-0.9 IU per µg of DNA) for 20 min at room temperature and analyzed by 
agarose gel electrophoresis.  
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3.2.4 Ethidium Bromide (EB) Exclusion 
Polymer solutions were added to premixed EB solution and plasmid solution with 
varying N/P ratios from 1/8 to 16 and incubated for 30 min. the intensity of EB 
fluorescence was recorded by a  Bio-Tek Synergy HT plate reader with excitation 
wavelength of 530/25 nm and emission wavelength of 590/35 nm. DNA/EB solution 
without any polymer was used as a control. 
3.2.5 Circular Dichroism 
Polyplexes were prepared at an N/P ratio of 8 at a final volume of 200 µL by 
adding 100 µL of the polymer solution with the final concentration of 0.625µg/µL to 100 
µL pCMV-Luc plasmid DNA (Elim Biopharmaceuticals) solution (0.25 µg/µL) in 20mM 
HEPES. The complexes were then incubated at room temperature for 30 min prior to 
analysis. The secondary structure of the DNA plasmid was measured using a J-815 
Spectropolarimeter (JASCO, Easton, MD). The polyplex samples were run using 200 µL 
of solution at a wavelength range of 220 to 320 nm at a scanning speed of 50 nm/min at 
25° C. A total of 5 accumulations were collected for each sample. Naked luciferase DNA 
plasmid and polymer only (for each polymer) were run as positive and negative controls. 
3.2.6 Polyplexes Stability in Serum Containing Medium 
Forty µL of polyplex solution containing 5 µg of Cy5-labeled plasmids DNA was 
added to another 40 µL of cell culture medium comprised of DMEM medium (1 g/L D-
glucose, L-glutamine, 110 mg/L sodium pyruvate) supplemented with 10% heat-
inactivated fetal bovine serum (FBS), 100 units/mL penicillin/streptomycin, and 10mM 
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HEPES (all cell medium components were from Gibco). Five µL of the polyplexes 
solution was removed immediately after dilution and after 1 h incubation at room 
temperature, placed onto a glass microscope slide, covered with a glass coverslip, and 
was observed under Nikon 100 motorized fluorescence microscope. 
3.2.7 Gene Transfection In Vitro 
NIH 3T3 murine fibroblasts (ATCC) were cultured in DMEM (1 g/L D-glucose, L-
glutamine, 110 mg/L sodium pyruvate, Gibco) supplemented with 10% fetal bovine 
serum (heat inactivated, Gibco) and 100 units/mL penicillin/streptomycin (Gibco). 
NIH 3T3 cells were plated at 5×10
4
 per well in 12-well plates and allowed to adhere 
overnight. After washing with phosphate buffered saline (PBS, pH7.4), the cell media 
was replaced with serum free media and polyplexes were added to the cells, incubated for 
4 h. The cells were then washed three times with PBS before replacing the serum free 
media back to regular cell media with 10% serum. Twenty-four hours after the initial 
addition of polyplexes, cells were washed with PBS, trypsinized, suspended in in FACS 
buffer (containing 1% bovine serum albumin, BSA, and 1 mM sodium azide in PBS) and 
analyzed by flow cytometry using LSR II flow cytometer (Becton Dickson) and FlowJo 
software. Cells transfected with luciferase encoding DNA were used as the control for 
any increased autofluorescence of cells caused by polyplexes nonspecifically. GFP-
positive cells were gated against the luciferase transfected control cells. 
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3.2.8 Injection 
Polyplex solutions were injected subcutaneously with a 29-gauge needle into the 
hind leg of 10 week old female Balb\c mice (Jackson Lab). Twenty-five µg of DNA 
complexed with polymers at an N/P ratio of 8 was prepared as described above and was 
injected into each mouse in a total volume of 200 µL. The same volume of naked DNA 
and buffer (5% glucose solution) only injections were also administered. Three mice per 
sample group were injected.  Polyplexes containing all six cationic polymers (PAEM30, 
5K PEG-b-PAEM30, 10K PEG-b-PAEM30, PAEM150, 5K PEG-b-PAEM150, and 10 K 
PEG-b-PAEM150) were tested for gene transfection in vivo. Only polyplexes containing 
the PAEM30 series polymers (PAEM30, 5K PEG-b-PAEM30, and 10 K PEG-b-PAEM30) 
were tested for biodistribution. All the mice were housed under specific pathogen-free 
conditions and cared for in accordance with the University of Minnesota and NIH 
guidelines. 
3.2.9 Gene Transfection In Vivo 
To assess gene transfection in vivo in live animals after subcutaneous injection, 
DNA plasmid encoding the luciferase gene (pCMV-Luc, Elim Biopharmaceuticals) was 
used to prepare the complexes. For luminescent signal measurement of luciferase 
expression, mice were given subcutaneous injection of D-luciferin (20 mg/mL), 
anesthetized using isofluorane at predetermined time points and imaged using IVIS 
Spectrum (Perkin Elmer). Three mice of the same experimental group were imaged 
together. The tails of the mice were marked to keep the order of mice (from left to right 
under the camera) the same for every time point. All images were taken at the stage 
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height and light position with a constant exposure time of 5 min. The bioluminescent data 
were processed using a constant region of interest (ROI) analysis with background 
subtraction using the Live Image software package (Perkin Elmer). 
3.2.10 Biodistribution  
To assess gene transfection in vivo in live animals after subcutaneous injection, 
Cy-5 labeled pCMV-Luc DNA plasmids were used to prepare the complexes. Mice were 
anesthetized using isofluorane at predetermined time points and imaged using IVIS 
Spectrum (Perkin Elmer). Three mice of the same experimental group were imaged 
together. The tails of the mice were marked to keep the order of mice (from left to right 
under the camera) the same for every time point. All images were taken at the stage 
height and light position with a constant exposure time of 1 ms. The fluorescence data 
were processed using a constant region of interest (ROI) analysis with background 
subtraction using the Live Image software package (Perkin Elmer). 
3.2.11 Statistical Analysis 
Comparisons between groups were made using Student’s t-test. A p-value of less 
than 0.05 was considered to be statistically significant. All results were presented as 
mean ± standard deviation (SD). 
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3.3 Results 
3.3.1 Average particle size and zeta potential  
 
Particle size is a key parameter in the design of polymeric drug delivery 
system[101]. It can affect the efficiency and pathway of cellular uptake and in vivo 
biodistribution [101-103], and can be precisely controlled by adjusting the reaction 
parameters[104]. DLS revealed that the average particle size of polyplexes in aqueous 
buffer spanned a range of 70 to 200 nm with dependence on the N/P ratio and chain 
length (Fig. 13). The size distribution of each type of polyplexes was narrow with PDC 
ranging from 0.05 to 0.2. At neutral charge ratio, the shorter PAEM block group 
(PAEM30, 5K PEG-b-PAEM30, 10K PEG-b-PAEM30) formed complexes with distinct 
larger particle sizes than the longer PAEM block group (PAEM150, 5K PEG-b-PAEM150, 
10K PEG-b-PAEM150), suggesting a chain length dependency of average particle size, 
which agreed with literature reported findings[105, 106]. Under this condition, 
polyplexes formed with PEGylated PAEM150 were significantly larger than those formed 
with homopolymers, which is in good agreement with literature reported finding[21]. At 
N/P ratio of 8, average particle size stabilized for all six polyplexes. Complexes formed at 
N/P ratio of 8 were selected for further characterization of polyplex stability, DNA 
binding capacity, in vitro and in vivo transfection, as well as biodistribution. 
At N/P ratio of 8, polyplexes of PAEM of different chain length shared similar 
zeta potential values around 35 mV (Fig. 14), suggesting a chain length independence of 
surface charge, which is in good agreement with our lab’s previous finding[76]. 
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Complexes formed with PEGylated polymers showed significantly lower zeta potential 
values than those formed with homopolymers, indicating an efficient shielding of the 
cationic charges by the PEG chains, which agreed well with literature reports[56, 60, 
107].  There was no significantly difference in zeta potential values for polyplexes 
formed with different PEG chains. 
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Fig. 13. Average particle size of polyplexes in aqueous buffer (20 mM HEPES, pH 7.4) 
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Fig. 14. Zeta potential of polyplexes at the N/P ratio of 8. The zeta potential is 
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3.3.2 DNA binding and condensation 
 
The gel retardation assay qualitatively revealed the difference in DNA binding 
ability among the six PAEM polymers. The PAEM150 group polymers were able prevent 
completely the migration of plasmid DNA at the N/P ratio of 1 and beyond (Fig. 15 A). 
However, at this neutral charge ratio, the PAEM30 group polymers were only be able to 
partially reduce the migration of plasmid DNA. Complete retardation of DNA migration 
happened at the N/P ratio of 2 and above. 
DNA binding and condensation capacity of various PAEM polymers were further 
quantified by EB exclusion assays. Addition of increasing amounts of polymers to a 
solution of EB/DNA results in a rapid decrease in fluorescence. A relative binding 
affinity of the polymers can be inferred from the residual fluorescence of EB/DNA 
solutions[108]. The ability to condense DNA increased with the chain-length of PAEM 
block, showed by the lower N/P ratios at which half of the EB was displaced from 
intercalating with DNA, resulting in reduced fluorescence intensity (Fig. 15 B). Lower 
charge ratios were required for PEGylated polymers to quench fluorescence of EB/DNA 
to the same extent as the equivalent homopolymers. 
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Fig.15. Capacity of DNA binding and condensation by the PAEM polymers with 
different chain length and PEGylation. (A) Gel retardation assay of polyplexes prepared 
at various N/P ratios. Arrows point to the threshold N/P ratio where retardation of DNA 
migration through the gel occurred. (B)  Ethidium bromide (EB) exclusion due to 
polyplex formation. Fluorescence intensity of EB mixed with plasmid without addition of 
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3.3.3 Polyplexes stability 
 
The stability of polyplexes at N/P ratio of 8 was studied in the presence of 
increasing amount of heparin, a polyanion that can compete with DNA for the binding to 
the polycation, followed by agarose gel electrophoresis. The greater amount of heparin 
needed to dissociate the polymer from the plasmid DNA, the greater the binding affinity.  
The threshold concentration of heparin at which polyplex disruption occurred was 0.3 
and 0.4 IU/µg of DNA for polyplexes formed with PAEM30 and PAEM150 respectively 
(Fig. 16), suggesting that the longer chain-length of homopolymer can protect complex 
dissociation better than the shorter chain-length. PEGylation of PAEM did not alter the 
threshold value of the heparin concentration needed for complex dissociation. However, 
the threshold amount of heparin required to disrupt the polyplexes was 0.5 IU/µg of DNA 
for PEGylated PAEM30 polymers, indicating a decrease in polyplex stability by adding 
the PEG chain to the homopolymer. 
 The interaction of the polycationic polymer with DNA plasmid can also be 
studied by evaluating the changes of the DNA structure by Circular Dichroism (Fig. 17). 
The naked Luc DNA control showed a characteristic β-form profile with a negative peak 
at 244 nm and a maximum peak at 274 nm. With the addition of polymer to the Luc 
plasmid, the maximum positive peak experienced a red shift and a decrease in magnitude 
of the positive peak. This suggested that the DNA plasmid underwent a conformational 
change form β-form structure into a c-form secondary structure[109]. The negative peak 
also underwent a change in magnitude while undergoing a red shift affecting the helicity 
of the DNA plasmid[110]. With the addition of the PEG chain to the homopolymers, a 
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smaller red shift in the positive and negative peaks accompanied by an increase in 
magnitude were observed, suggesting a weaker DNA binding capacity of PEGylation, 
which agreed with the heparin assay result. Though there was no significant difference in 
the spectra shift between homopolymers of different chain-lengths, PEGylated PAEM150 
polymers showed a greater spectra shift than the PEGylated PAEM30 polymers, 
suggesting a stronger DNA binding capacity of the PEGylated PAEM150 polymers. 
 














































Heparin (IU/µg DNA) 
Fig. 16. Destabilization 
of polyplexes with 
increasing concentration 
of heparin. Arrows 
point to the threshold 
concentration of heparin 
beyond which 
unpackaging of DNA 
occurred. 
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Fig.17. Configuration of DNA packing by complexation with cationic polymers 
measured by Circular Dichroism. With the addition of the polymers to the DNA plasmid, 
the maximum positive peak experienced a red shift and a decrease in magnitude of the 
positive peak. This suggested that the DNA-plasmid underwent a conformational change 
from the B-form structure into a C-form secondary structure. PEGylated PAEM150 
polymers experienced a red shift and decrease in magnitude of the negative peaks 
compared to PEGylated PAEM30 polymers, suggesting chain length affecting DNA 
secondary structure in PEGylated polymers.  
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3.3.4 Visual assessment of polyplex stability in simulated in vivo media 
 
Polyplexes containing Cy5-labeld plasmid DNA were dissolved in full cell culture 
medium supplemented with 10% serum and buffer salts to mimic the in vivo fluid 
environment, and visualized by fluorescence microscopy (Fig. 18). The fluorescence 
microscopy method we employed here provided a direct visualization of the aggregation 
process. Shortly after mixing, aggregates of PAEM30 and PAEM150 polyplexes were seen 
in the serum containing medium, and the aggregates become more serve after 1 h (Fig. 
18). Qualitatively, aggregates of PAEM150 polyplexes were bigger than the PAEM30 
polyplexes. No visible aggregation was seen in the PEGylated polyplexes after 1 h in 
complete cell culture medium PEGylation enhanced polyplexes stability against 
aggregation, and the longer PEG chain performed slightly better than the shorter PEG 
chain.






Fig.18. Visual assessment of polyplex stability in cell medium containing 10% serum, 
condition that mimics the in vivo fluid environment.  
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3.3.5 Transfection of murine fibroblasts in vitro 
 
Polyplex-mediated transfection of murine fibroblasts NIH 3T3 with a GFP 
plasmid was conducted and the expression level of GFP was determined by flow 
cytometry (Fig. 19). Cell autofluorescence was subtracted by transfecting the 3T3 cells 
under the identical conditions with a luciferase plasmid serving as a negative control to 
set the GFP positive gate. Polyplexes made from PEI and GFP plasmid were given to the 
fibroblast under the same transfection condition to provide a positive control and a 
standard for comparison. For both two rounds, PEI/DNA polyplex resulted in a 
transfection efficiency around 42%, which agreed well with our previous finding reported 
in literature[31].  The fibroblasts received PAEM30/DNA complexes had only 5% GFP
+
 
cells, and those received the PEGylated complexes showed less than 1% GFP
+
 cells. On 
the other hand, PAEM150/DNA polyplexes led to an almost 40% GFP
+ 
cells observed, 
which was statistically the same as PEI/DNA polyplex treated group. The PEGylated 
PAEM150 complexes generated much less GFP
+ 
cells (about 5%), and there was no 
statistical difference seen between groups with different PEG chains. 
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Fig.19. Transfection efficiency of NIH 3T3 fibroblasts by polyplexes (A), PAEM30  
series and (B), PAEM150 series, determined by flow cytometry. Longer polymer chains 
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3.3.6 Transfection in vivo 
 
Polyplexes containing all 6 polymers were injected subcutaneously into the hind 
quadriceps region of mice and the mice were imaged live using IVIS Spectrum starting 
one day after injection and monitored every day or every other day after that (Fig. 20). 
Five percent glucose solution at the same total final volume was administered to a mouse 
to serve as a negative control and to provide the measurement of any luminescent signal 
coming from the tissue itself. After subtracting the background luminescence, mice 
injected with PAEM30 series polyplexes showed positively transfected cells, but none of 
the PAEM150 series polyplexes generated detectable luminescent signals. One day after 
the initial injection, mice received complexes made of 10K PEG PAEM30 showed 
significantly higher transgene expression, about 4 times higher than other polyplexes. On 
the other hand, mice received the polyplexes of homopolymers PAEM30 did not generate 
any luminescent signal on day 1, but showed a peak of luminescent intensity on day 7 
after the initial injection, which was significantly higher than other two polyplexes. 
Interestingly, mice received 5K PEG PAEM30 polyplexes showed a stable transgene 
expression throughout the time course of study.  
The data reported in Fig. 20 B and C were after background subtraction and 
normalized against the average of background luminescent signals collected from 3 mice 
received buffer injection. They were expressed as a percentage of the background 
luminescent signal. 
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Fig. 20. Transfection of poplyplexes in live animals. Three or five mice were injected 
with polyplexes containing 25 µg of luciferase plasmid DNA in the right hind quadriceps 
region with subcutaneous injection. (A) Visualization of PAEM30 series polyplexes 
transfection. (B) Quantification of PAEM30 and PAEM150 series polyplexes transfection 
normalized against background luminescent signals. * p<0.05. (C) Visualization of 
PAEM150 polyplexes transfection. (D) Visualization of 5K PEG PAEM150 polyplexes 
transfection. (E) Visualization of 10K PEG PAEM150 polyplexes transfection. 
Day 3 Day 5 
Day 1 Day 2 
E 
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3.3.7 Biodistribution of PAEM30 series polymers 
To determine the persistence and clearance kinetics of the naked DNA plasmid 
and polyplexes, we monitored the fluorescence signals of Cy5-labeled plasmid DNA 
either by itself or in complexes after subcutaneous injection into the hind quadriceps 
region of mice using whole-animal live imaging with IVIS Spectrum (Fig. 21). After 
subtracting background and tissue autofluorescence, the measured fluorescence intensity 
was normalized against the measured fluorescence signal on day 0 right after the 
injection. Two days after the initial injection, 85% of the naked plasmid DNA was 
cleared from the injection region. However, only 65% of the fluorescence signal was 
cleared in PAEM30 polyplex injected mice. Throughout the time course of study, a larger 
amount of labeled DNA plasmid was present in mice received in PAEM30 polyplexes 
than naked plasmid DNA. PEGylation helped to reduce DNA clearance 2 days after 
injection and was able to reserve a larger amount of DNA in the injection region than 
naked DNA, but not as much as the homopolymer. 
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Fig. 21. In vivo performance of the PAEM30 series polyplexes. (A) Tissue distribution of 
polyplexes in live animals after subcutaneous injection. Three mice were each injected 
with polyplexes containing 25 µg of Cy5-labeld DNA in the left hind quadriceps region. 
(B) Tissue distribution of naked DNA in live animals after subcutaneous injection of 25 
µg Cy5-labeld DNA in the left hind quadriceps region. (C) Quantification of total 
fluorescent signal intensity reduction. 
C 
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3.4 Discussion 
 
Designing an efficient non-viral gene delivery vehicle needs the understanding of 
specific structural features and stability requirements in order for the vehicle to remain 
intact when it maneuvers through the extracellular space or vasculature to reach its 
targeted cell types before releasing its cargo. Molecular weight or length of the polymer 
chain is a critical factor influencing polyplex-mediated transfection efficiency in vitro. 
Many studies have shown the positive correlation between chain length and transfection 
efficiency for a variety of polymers [18, 76, 105, 111] though discrepancies existed. In 
the work here, we observed that the homopolymer with a longer polymer chain 
(PAEM150) generated a higher transgene expression when complexed with plasmid DNA 
and delivered to murine fibroblasts in vitro. This is because PAEM150 was able to form 
more stable complexes than PAEM30 (as shown in the gel retardation and EB assay 
results (Fig. 15)), which facilitated a higher cellular uptake and a higher nuclear uptake of 
the polyplexes by the fibroblasts[76]. 
However, the trend we observed for in vivo transfection was the opposite of the 
result of the in vitro transfection. Polyplexes made of PAEM150 generated much lower 
transgene expression in mice than those of PAEM30 (Fig. 20). This is not surprising 
because studies done by various researchers have shown that in vitro transfection could 
be a poor indicator of in vivo success[112-114]. The big discrepancy between in vitro and 
in vivo results lies in the fact the nanocomplexes need to overcome the extracellular 
barrier while remain as stable complexes before they present themselves for efficient 
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cellular uptake. Biomacromolecules, such as serum albumin[115, 116], present in skin 
tissue and they could non-specifically interact with polyplexes, inducing their 
dissociation or aggregation [55]. To understand the effect of serum protein on polyplexes 
aggregation, we conducted the in vitro experiment in simulated body fluid environment 
by incubating polyplexes made of fluorescently labeled DNA plasmid in complete cell 
culture medium containing serum. With direct visualization through fluorescence 
microscopy, we observed that PAEM150 formed considerable aggregates after 1 h 
incubation. Consistent with our in vitro finding, a previously published study by our 
group has shown that PAEM150 polyplexes formed aggregates at the injection site through 
immunofluorescence staining of skin specimen of polyplexes treated mice[117]. The 
polyplexes remained as aggregates throughout the 4 day of investigation and the large 
aggregates had limited diffusivity in the skin tissue. There could be very little PAEM150 
polyplexes left to interact with cells, resulting in a low transfection in the skin tissue. 
Interestingly, PAEM30 polyplexes had similar particle size and zeta potential as 
PAEM150 polyplexes at N/P ratio of 8 when measured in vitro in buffer solution (Fig. 13, 
Fig. 14), but PAEM30 polyplexes generated detectable transgene expression after 
subcutaneous injection in mice (Fig. 20). This agrees with the literature reported 
molecular-weight-dependency of polyplexes transfection in vivo. Turunen and 
colleagues, as well as Abdallah and colleagues have found a higher transfection 
efficiency with lower molecular weight PEI in vivo[112, 118]. Hoggard and colleagues 
reported a superior transgene level with lower molecular weight chitosan oligomers[119]. 
This could be due to the difference in polyplex stability between them. From the physical 
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characterization assays, PAEM30 homopolymer needed a higher N/P ratio to completely 
prevent DNA migration and quench EB fluorescence than PAEM150. At the same time, a 
smaller amount of heparin was necessary to disrupt complex association for PAEM30 
polyplexes than PAEM150 polyplexes. The lower DNA binding capacity combined with 
the reduced chain entanglement effect resulted in a less stable complex formed with 
PAEM30 than PAEM150. The PAEM30 complexes are more easily dissociated to release 
the DNA cargo, which could be the possible explanation for the high level of transgene 
expression as reported by Hoggard and colleagues[120]. In addition to the polyplex 
stability, our in vitro data with the simulated body fluid, PAEM30 polyplexes formed 
much smaller and fewer aggregates than PAEM150 polyplexes. It is also possible that 
PAEM30 polyplexes had better diffusivity than PAEM150 polyplexes in a large aggregate, 
and therefore they could have a better chance to interact with cells. 
The net positive charges on the surface of polyplexes induce non-specific 
interactions with anionic components in the body such as serum albumin or negatively 
charged molecules in the ECM [49]. This leads to the formation of distinct large 
aggregates with size in the micrometer range and persisting for a long time[58]. To 
minimize the undesired interactions of anionic components with polyplexes, surface 
shielding is essential in the design of gene delivery vehicles. One of the most extensively 
developed approaches involves the integration of the flexible hydrophilic PEG chain into 
polyplexes[121, 122]. Nomoto and colleagues observed directly the stabilization against 
aggregation by PEGylated polyplexes after intravenous injection in vivo[58]. In our in 
vitro experiment with the simulated body fluid incubation, we did not see any 
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aggregation of PEGylated polyplexes (Fig. 20). Consistent with the in vitro finding here, 
our previous study in live animal showed a broader dispersion of PEGylated polyplexes 
after intradermal injection in mouse skin and many smaller aggregates spread out in the 
skin tissue. 
However, PEGylated PAEM150 polyplexes did not show any detectable transgene 
expression in vivo either. This could be caused by the “PEG dilemma” that transfection 
efficiency is compromised due to the reduced cellular internalization and endosomal 
escape of PEGylated polyplexes.  
PEGylated PAEM30 has a shorter polymer chain than PEGylated PAEM150, and 
therefore the amount of positive charge per molecule is smaller for PEGylated PAEM30. 
To achieve the same N/P ratio as the PEGylated PAEM150 polyplex, we would need more 
PEGylated PAEM30 molecules per complex. Looking from the outside of the complex, 
there would be a higher density of the PEG chain on the surface of the complex. PEG 
density affects the stabilization of polyplexes and Storm and colleagues have proposed 
that a high surface density of PEG chain would decrease the steric hindrance protection 
of the PEG layer because the lateral movement of the PEG chain is more limited, 
resulting in weaker DNA binding capacity of the polyplexes[59]. PEGylated PAEM30 
polyplex may behave similarly to PAEM30 polyplexes in vivo. They could become 
relatively easily dissociated and release the DNA cargo for gene transfection. 





Fig. 22. A schematic summary of the finding. We studied the characteristics and 
properties of polyplexes in vitro to provide understanding of their behavior for local in 
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3.5 Conclusions 
We performed in vitro physical characterization of polyplexes formed from six 
different polymers in order to understand their in vivo performance. Homopolymer with a 
larger molecular weight (and polymer chain) was able to transfect cells in vitro, but not in 
vivo. On the other hand, a shorter polymer chain favored in vivo transfection. PEGylation 
helped the polyplexes to be stable against serum protein, but PEGylation of long chain 
homopolymer did not improve its in vivo performance. Taken together, these findings 
could help us gain a better understanding of polyplex in vivo performance based on its in 
vitro behavior and therefore providing insight into the design of gene delivery vehicle. 
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Chapter 4: Overall Conclusions and Future Prospects 
Much effort has been given to developing cationic polymeric gene delivery system 
that will achieve high transfection efficiency and low cytotoxicity. This thesis studies the 
in vitro properties and characteristics of polymer/DNA complex in order to understand 
their in vivo performance. Understanding the mechanisms and pathways underlying 
toxicity associated with polyplex-mediated gene delivery could provide insight in 
designing new polymers with a safer profile. In Chapter 2, we used the widely studied 
polymer PEI as a model polymer to explore the existence of the newly recognized form 
of cellular cytotoxicity. We have successfully confirmed the presence of autophagy 
associated with polyplex-mediated gene delivery using 3 different methods in vitro. The 
3 modalities of cell death often have a cross talk and apply a compound effect on cellular 
cytotoxicity. To better understand the effect of autophagy alone on gene transfection 
efficiency, we decoupled autophagy from apoptotic and necrotic cell death and reported a 
positive correlation between gene delivery efficiency and autophagy regulation. This 
provided another option to regulate transgene expression. 
The above mentioned work was done with cell culture in vitro. Artificial 
manipulation of autophagy in vivo involves ischemia, exposure to cadmium or pathogens 
and 3-MA [123-126], but polymer-based gene carriers have not been tested. In vivo 
studies of apoptosis were based on pathogen invasions or treating tumor cells with 
chemotherapeutic drugs [127-129], but not involving polymeric gene carriers either. It is 
important to confirm the induction of different programmed cell death (PCD) pathways 
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by polymer gene carriers in vivo before we implement new polymer design or drug 
treatment to alter PCDs in vivo.  
Due to the limited number of biomarkers for autophagy detection, the standard 
method to date for monitor autophagy in vivo has been transmission electron microscopy 
(TEM) [42, 80, 123, 130]. Autophagy detection through TEM involves the recognition of 
changes in cell morphology such as extensive vacuolization, formation of membranous 
whorls and depletion of organelles. However, it is often difficult to distinguish 
autophagic vacuoles from other cellular structures. Autophagy detection using 
fluorescence microscopy on tissue sections for LC3 staining is an alternative solution to 
the conventional approach since LC3 is a distinct biomarker for autophagy. 
TUNEL assay is a common method for visualizing and quantifying apoptosis in vivo 
that requires processing tissue post-mortem [131, 132]. Non-invasive detection of 
apoptosis in live animals has been reported recently [127, 128]. Z-VED-aminoluciferin is 
a modified firefly luciferase substrate that can be cleaved by caspase-3 in apoptotic cells. 
It will liberate aminoluciferin, a substrate for luciferase to generate luminescence signals 
that can be detected and quantified using a live imaging instrument such as the Xenogen 
IVIS system. The new technique will allow us to track the kinetics of apoptosis induction 
by polymer gene carrier continuously and non-invasively in live animals after polyplex 
administration. 
In Chapter 3, we tackled the other hurdle in polymeric based gene delivery, which is 
the general low transfection efficiency in vivo compared to the viral vectors. Literature 
has reported a variety of factors potentially influencing gene transfection efficiency in 
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vitro. However, the understanding for polyplex performance in vivo remains much 
unclear. In this study, we synthesized a PAEM diblock copolymer in our lab which has a 
nearly uniform distribution of chain length and well-defined chemical structure [67]. We 
performed a comprehensive analysis of polyplex characteristics in vitro in order to 
compare their in vitro properties with in vivo performance. We identified molecular 
weight or polymer chain length is the dominant factor influencing both in vitro and in 
vivo transgene efficiency though with opposing trend. We attributed this difference to 
their varied stabilities under different environment. Further experiment could be 
conducted to confirm this speculation, especially the polyplex stability, DNA binding and 
condensation capacity under the influence of serum protein and ECM components. Burke 
and Pun have examined the extracellular barriers for PEI and PEGylated PEI in vivo 
delivery to the liver [49], but a more detailed examination on the effect of chain length on 
polyplex stability due to the interaction with ECM components and serum proteins is 
much needed. 
PEGylated polyplexes have been shown to be more stable in serum containing cell 
culture media in this study. They have a better chance to diffuse through a larger area in 
the skin tissue and remain intact in order to interact with cells. PEGylation has often 
come with compromised transfection efficiency and this could very likely contribute to 
the non-significant difference between homopolymer and PEGylated PAEM30 in vivo 
transfection efficiency. It would be of great interest and benefit for a better design of gene 
carrier to manipulate the PEG chain in the hope to further improve the in vivo 
transfection efficiency. 
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Researchers have tried to lose the PEG chain after the polyplexes being internalized 
by cells. Wagner and colleagues have developed hydrazine derivative as the linking 
structure between PEG and PLL, demonstrating a pH-responsive chemistry to un-shield 
the PEG protection on polyplexes [133]. While still being able to retain polyplex 
stability, their pH-responsive PEGylated polymer was able to improve the gene 
transfection 2 logs order of magnitude in vitro, and 1 order of magnitude in vivo. It would 
be very interesting to investigate a detachable PEG chain with our PAEM30 series 
polymer in the hope to further improve in vivo gene delivery efficiency. 
Instead of dropping the PEG chain, another approach to solve the problem associated 
with PEGylation, which is the low cellular internalization, is to introduce a target specific 
ligand to the distal end of the PEG chain. Kursa and colleagues have added transferrin to 
PEGylated PEI, and found the transfection efficiency was greatly improved in tumor cells 
in vivo [134]. Kim and colleagues explained that the targeted PEGylated polyplexes 
showed selectively enhanced gene expression only in cells expressing the receptors [135]. 
Oba and colleagues further explored and discovered that this enhanced transfection is 
highly correlated with the facilitated cellular internalization of polyplexes via receptor-
mediated endocytosis [136]. The ligand introduction techniques can also be utilized for 
enhanced endosomal escape of PEGylated polyplexes [133]. In this design, the target 
specific ligand is grafted on the longer PEG chain. When the longer PEG chain is 
detached, the endosomal disrupting component will be exposed, mediating endosomal 
escape. The combination of detachable PEG and ligand targeting could be an interesting 
topic to explore with our polymer system. 
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Appendix 1: Visualization of PEI-mediated transfection 
efficiency and associated cytotoxicity in NIH 3T3 murine 
fibroblast by fluorescence microscopy 
A 1.1 Method 
 
A 1.1.1 Visualization of PEI-mediated transfection efficiency in NIH 3T3 murine 
fibroblast by fluorescence microscopy 
PEI (branched, 25 kDa, Sigma) and plasmid DNA stock solutions, both at the 
concentration of 1 mg/mL, were diluted to 0.1 mg/mL in 20 mM HEPES buffer (pH7.4). 
Polyplexes were prepared at N/P ratios from 4 to 20 by vortex mixing equal 
concentrations of PEI and plasmid DNA in 20 mM HEPES buffer to a total volume of 
100 µL, and allowed to incubate at room temperature for 30 min. A plasmid encoding 
enhanced green fluorescence protein (GFP) (pEGFP-N1, Elim Biopharmaceuticals) was 
used to investigate the transfection efficiency. A plasmid encoding the luciferase gene 
(pCMV-Luc, Elim Biopharmaceuticals) was used to serve as a negative control and gate 
for cell autofluorescence.  
NIH 3T3 murine fibroblasts (ATCC) were cultured in DMEM (1 g/L D-glucose, 
L-glutamine, 110 mg/L sodium pyruvate, Gibco) supplemented with 10% fetal bovine 
serum (heat inactivated, Gibco) and 100 units/mL penicillin/streptomycin (Gibco). 
NIH 3T3 cells were plated at 5×10
4
 per well chamber slides and allowed to adhere 
overnight. After washing with phosphate buffered saline (PBS, pH7.4), the cell media 
was replaced with serum free media and polyplexes were added to the cells, incubated for 
4 h. The cells were then washed three times with PBS before replacing the serum free 
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media back to regular cell media with 10% serum. Twenty-four hours after the initial 
addition of polyplexes, cells were washed with PBS, counterstained with 1:200 diluted 
Hoechst 33342 (Invitrogen) and mounted with Vectashield. The cells were visualized 
using an Olympus IX70 inverted microscope equipped with a standard 
FITC/TRITC/DAPI filter set and Olympus DP72 camera, and analyzed using CellSens 
software. 
A 1.1.2 Toxicity study in PEI-mediated gene delivery by TUNEL staining 
We determined apoptosis of PEI-mediated gene transfection in fibroblasts through 
TUNEL staining. At the end of the 24 h transfection, cells undergoing apoptosis and 
DNA fragmentation were examined using DeadEndTM Colorimetric TUNEL system 
(Promega). Cells were washed twice with PBS and fixed by immersing in 4% 
paraformaldehyde (Sigma) for 25 min at room temperature. After two 5-min washes with 
PBS, cells were permeabilized with 0.2% Triton X-100, washed twice with PBS and 
equilibrated in  100 µL of Equilibrium Buffer for 10 min. Recombinant terminal 
deoxynucleotidyl transferase (rTdT) of 100 µL was added to each sample, and slides 
were covered with plastic coverslips to ensure even distribution of the reagent. After a 60 
min incubation at 37 °C in a humidity chamber, the reaction was stopped by immersing 
cells in 2-times SSC buffer in a Coplin jar for 15 min at room temperature, followed by 3 
washes with PBS. Cells were then incubated with 0.3% hydrogen peroxide for 5 min, 
washed three times with PBS, and treated with 100 µL of horseradish peroxidase-labeled 
streptavidin for 30 min at room temperature. After three more washes in PBS, cells were 
stained with 100 µL of diaminobezidine (DAB) for 8 min at room temperature and 
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washed three times with de-ionized water. Slides were mounted using Bectashield and 
visualized using an Olympus IX70 inverted microscope equipped with Olympus DP72 
camera, and analyzed using CellSens software. 
A 1.2 Results 
NIH 3T3 cells were transfected with PEI/DNA complexes of different N/P ratios 
for 4 h in serum free media and analyzed using fluorescence microscopy (Fig. 23). The 
GFP positive cells are green and the nuclei are stained blue. Qualitatively, the polyplexes 
were able to transfect fibroblasts efficiently, especially at lower N/P ratios like 4 and 8. 
The fraction of GFP positive cells seemed decreasing at higher N/P ratios (12, 16 and 
20). This agreed well with our previously published paper where transfection efficiency 
was quantified through flow cytometry [31].  
 Apoptosis was also visualized through TUNEL assays (Fig. 24). Brown staining 
is indicative of apoptotic cells. At lower N/P ratios (4 and 8) there were little brown 
staining, suggesting minor cytotoxicity. At higher N/P ratios (12, 16 and 20), the fraction 
of apoptotic cells increased. This agreed well with our previously published paper where 
transfection efficiency was quantified through flow cytometry [31]. 
  104 
 
Fig. 23. Visualization of PEI-mediated gene delivery. A representative set of images of 
24 h transfected and untreated NIH 3T3 fibroblasts. GFP positive cells are green and the 
nuclei of all cells are blue. Scale bar: 100 µm. 
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Fig. 24. Visualization of cytotoxicity (apoptosis) associated with PEI-mediated gene 
delivery. A representative set of images of transfected cells with brown staining 
indicative apoptotic cells. Scale bar: 100 µm. 
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Appendix 2: In Vivo transgene expression by 
immunohistochemical fluorescence staining for PAEM 
polymers 
A 2.1 Method  
A 2.1.1 Intradermal gene delivery  
Hair was removed from the skin on the hind leg of 10-week old Blab\c mice 
(Jackson Labs) to mark the injection site, and polyplex solutions were injected 
intradermally through a 29-gauge needle. Forty µg of Luciferase plasmid DNA 
complexed with polymers at N/P ratio of 8 was prepared as described above and was 
injected into each mouse in a total volume of 35 µL. Three polymers with distinctly 
different chemical structures were used: branched PEI, linear PAEM150, and diblock 
copolymer PEG-PAEM150. Naked plasmid DNA was diluted to the same final volume as 
the polyplexes with 5% glucose buffer. The same volume of the buffer solution was also 
administered to serve as a negative control. All the mice were housed under specific 
pathogen-free conditions and cared for in accordance with the University of Minnesota 
and NIH guidelines. 
A 2.1.2 In Vivo transgene expression by immunohistochemical fluorescence staining 
Mice were sacrificed with CO2 1 day or 4 days after injection and the skin around each 
injection site was removed, embedded in OCT medium and snap-frozen with liquid 
nitrogen. The frozen skin samples were cut into 10 µm thick sections using a cryotome 
and placed on SuperFrost glass slides. The cryosections were dried at room temperature 
for 1 h then fixed in cold acetone. After equilibrating the skin specimens to room 
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temperature, a hydrophobic circle was drawn around the specimens with a PAP pen and 
the specimens were soaked in PBS for 30 min with slight agitation. The tissue sections 
were blocked with 5% non-fat dry milk in PBS with 0.1% Tween-20 for 30 min at room 
temperature in a humidity chamber, followed by staining with 1:100 diluted anti-
luciferase-FITC conjugated antibody (Lifespan Biosciences) in the blocking buffer for 1 
h. after washing the tissue sections 3 times with PBS, the specimens were counterstained 
with 1:200 diluted Hoechst 33342 (Invitrogen) and mounted with Vectashield. The tissue 
sections were visualized using an Olympus IX70 inverted microscope equipped with a 
standard FITC/TRITC/DAPI filter set and Olympus DP72 camera, and analyzed using 
CellSens software. 
A 2.1.3 Colocalization study by immunohistochemical fluorescence staining 
After the tissue sections were stained for luciferase expression as described above, the 
slides were probed for dendritic cell marker CD11c to study the cell type of luciferase 
positive cells. Tissues were blocked using Blocking Buffer (from Tyramide Signal 
Amplification (TSA) Biotin System, Perkin Elmer) for 30 min, followed by  streptavidin 
and biotin solutions (Vector Laboratories) for 15 min each in the humidity chamber.  
Slides were then stained with biotin-labeled anti-CD11c (Biolegend) for 30 min followed 
by biotin-labeled anti-rabbit IgG (Invitrogen) for 1 h. signal was developed using TSA 
Biotin System (Perkin Elmer) and a streptavidin labeled with Alexa Fluor 350 
(Invitrogen). Tissue sections were mounted with Vectashield and using an Olympus IX70 
inverted microscope equipped with a standard FITC/TRITC/DAPI filter set and Olympus 
DP72 camera, and analyzed using CellSens software. 
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A 2.2 Results 
Naked luciferase plasmid and different polyplexes containing PEI, PAEM150, and PEG-
PAEM150, were injected intradermally into the hind quadriceps region of mice. After day 
1 and 4, animals were sacrificed. The dermal tissue of the injection sites was harvested, 
cryosectioned, stained with Hoechst for cell nuclei (blue) and with a fluorescein-labeled 
polyclonal antibody against luciferase (green), and imaged under a fluorescence 
microscope. The skin sections included the epidermal and dermal tissue as shown in Fig. 
25. We can see that mice received naked plasmid and the polyplexes all contained skin 
cells positively transfected with luciferase gene. On the other hand, mice receiving buffer 
only injections did not show any detectable luciferase signal. The number of luciferase 
expressing cells in mice with naked plasmid and polyplexes were qualitatively 
comparable on day 1(Fig. 25A), but polyplexes appeared to have transfected more skin 
cells in mice than the naked plasmid on day 4 (Fig. 25B). Polyplexes may be able to 
provide protection for the plasmid from enzymatic degradation, providing sustained 
presence of plasmid in the local tissue and leading to the prolonged local gene 
transfection in vivo. Results from our previously published work strongly suggested the 
depot effect created by polyplex gene delivery in vivo [117].  









Fig. 25. Transgene expression in the skin of mice after intradermal injection in the right 
hind quadriceps region. A representative set of fluorescence microscopy images of mouse 
skin cross-sections. Luciferase expressing cells (green) were detected by a polyclonal 
antibody against luciferase. Cell nuclei were stained blue (Hoechst). Scale Bar: 50 µm. 
(A) One day after injection, and (B) four days after injection. 
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